Award winning scientist, inventor, biostatistician, scientific advisory board member, juris doctor and licensed patent agent with 39 years experience in research, development, clinical/regulatory, biostatistics, and project management resulting in 51 commercialized products in the United States (9 drugs, 42 in vitro diagnostic assays and medical devices), 1 MAA approval, as well as 7 CE Marked products. Clinical areas of expertise: cardiovascular, diabetes, asthma, rheumatology, metabolic bone disease, infectious disease, oncology, gastroenterology, chronic pain management, reproductive hormones, fetal aneuploidies, thrombophilia and coagulation monitoring, male fertility, cognitive impairment, and newborn screening for inherited disorders; Recently published in Lancet Infectious Diseases, Journal of Urology, Urology, Food and Drug Law, Journal of the American College of Cardiology, Bone, Journal of Bone and Mineral Research, Clinical Chemistry, Clinical Biochemistry, Pediatric Infectious Disease Journal, Clinical Chemistry & Laboratory Medicine, Life Sciences, Journal of Clinical Pharmacology, Journal of Clinical Oncology, Diabetes Technology and Therapeutics, Drug and Chemical Toxicology, Arthritis & Rheumatism, Clinica Chimica Acta, Cancer Research, Gynecologic Oncology, Prostate Cancer and Prostatic Diseases, Journal of Breath Research, Fertility and Sterility, Hypertension, and Diabetes Care. Journal Reviewer for Clinical Chemistry. For more information, see Mark's Curriculum Vitae.

Contact Mark:

email: Mark Sarno
P.760.591.4945